Search Results

Displaying Results 8801-8825 of 12274 "'L'"

Jan 28, 2026, 06:45 ET PROSPERITY BANCSHARES, INC.® REPORTS FOURTH QUARTER 2025 EARNINGS

AverageYield/Rate(L)AverageBalance

More news about: Prosperity Bancshares, Inc.


Jan 28, 2026, 06:40 ET Un nuevo estudio identifica una inflamación oculta del cuero cabelludo que podría explicar por qué los tratamientos contra la alopecia con patrón androgenético dejan de funcionar

culta-del-cuero-cabelludo-que-podria-explicar-por-que-los-tratamientos-contra-la-alopecia-con-patron-androgenetico-dejan-de-funcionar-302672575.htmlFUENTE Dr. U Hair and Skin Clinic

More news about: Dr. U Hair and Skin Clinic


Jan 28, 2026, 06:15 ET Epson Thermal Receipt Printers Integrated into LaunderPay Point-of-Sale Solution for Laundry Businesses

OmniLink® TM-L100 liner-free label printer. Laundry bags come in various materials like canvas, cotton, polyester or nylon and require label options that will adhere to the bags. The TM-L100 label printer offers Epson's most flexible liner-free media

More news about: Epson America, Inc.


Jan 28, 2026, 06:00 ET Danaher Reports Fourth Quarter and Full Year 2025 Results

strengthened Danaher's position as a trusted leader in life sciences and diagnostics.Cytiva expanded its Xcellerex X-platform bioreactor with 500L and 2,000L formats, helping customers improve yields while reducing the time and cost of biologic manufacturing.SCIEX introduced the ZenoTOF 8600

More news about: Danaher Corporation


Jan 28, 2026, 04:35 ET Yutong Bus Reports Continued Sales Growth in 2025, Advancing Sustainable Public Transportation Worldwide

Nordic countries, demonstrating adaptability under diverse operating conditions. In Ghana, Yutong V6 van achieved a combined fuel consumption of 9.2 L/100 km. In Kazakhstan, the maximum operating mileage of a single Yutong C12Pro vehicle can reach 2 million km.

More news about: Yutong Bus


Jan 28, 2026, 03:40 ET Yutong Bus Reports Continued Sales Growth in 2025, Advancing Sustainable Public Transportation Worldwide

Nordic countries, demonstrating adaptability under diverse operating conditions. In Ghana, Yutong V6 van achieved a combined fuel consumption of 9.2 L/100 km. In Kazakhstan, the maximum operating mileage of a single Yutong C12Pro vehicle can reach 2 million km.

More news about: Yutong Bus


Jan 27, 2026, 18:08 ET Enhancing Workflow Efficiency with Monport's Fiber Laser and CO2 Laser Systems This Winter

to reduce bottlenecks, shorten turnaround times, and maintain consistent quality.Proper use of water chillers, such as Monport's 9L CW-3000 or 6L CW-5200 Industrial Water Chiller, ensures stable performance under continuous operation, an important factor for winter production schedules.Winter

More news about: Monport laser


Jan 27, 2026, 17:50 ET International Tower Hill Mines Closes Upsized US$115 Million Equity Financing, including Full Exercise of Underwriters' Option

paved Elliott Highway, 70 miles north of Fairbanks, Alaska.On behalf ofInternational Tower Hill Mines Ltd.(signed) Karl L. HannemanChief Executive Officer

More news about: International Tower Hill Mines Ltd.


Jan 27, 2026, 17:20 ET ASHFORD HOSPITALITY TRUST ANNOUNCES TAX REPORTING INFORMATION FOR 2025 PREFERRED SHARE DISTRIBUTIONS

or the "Company") today announced the tax reporting (Federal Form 1099-DIV) information for the 2025 distributions on its Series D, F, G, H, I, J, K, L and M preferred shares.  The amounts below represent the income tax treatment applicable to each distribution that is reportable in 2025. The preferred

More news about: Ashford Hospitality Trust, Inc.


Jan 27, 2026, 17:04 ET Tampa General Hospital Cancer Institute and USF Health Morsani College of Medicine to Host International Cancer Research Leaders for the "Microbes, Genes & Cancer" Symposium

academic health system, is a 1,530-bed not-for-profit network of hospital and outpatient services spanning across Florida. As the only center for Level l trauma and comprehensive burn care center serving 23 counties, Tampa General delivers world-class care. The system's hospitals include Tampa General Hospital,

More news about: Tampa General Hospital


Jan 27, 2026, 17:00 ET Dreame Unveils "Beyond Smart" Home Ecosystem in Silicon Valley, Showcasing a Future of Robotic Autonomy and AI-Powered Living

results simultaneously across two independent cooking zones. Its groundbreaking Dual-Zone Architecture features two fully independent cooking zones (5L CrispZone + 5L TenderZone), each with its own dedicated airflow system—the Crisp Cyclone Airflow for perfect dehydration and crunch, and the Tender Whirlwind

More news about: Dreame Technology


Jan 27, 2026, 16:36 ET Benson & Bingham Injury Law Welcomes Veteran Trial Attorney Douglas R. Brown, Esq. to the Team

Benson & Bingham and to fight for the rights of injury victims the firm represents."We are thrilled to have Doug join our team," said Joseph L. Benson II, Esq., Partner at Benson & Bingham. "I've known Doug for quite some time, dating back to our days at Wooster High School. His discipline

More news about: Benson & Bingham Accident Injury Lawyers


Jan 27, 2026, 16:24 ET engage2learn launches ReadyLab to help districts authentically assess employability skills at scale

engage2learnFounded in 2011, engage2learn (e2L) is a strategic transformation partner for public school districts, helping them rapidly and sustainably improve student outcomes and teacher retention through personalized, research-based support systems and its integrated GroweLab platform. e2L leverages its ESSA-validated

More news about: engage2learn


Jan 27, 2026, 15:00 ET New Survey Highlights Pill-Splitting Challenges in Parkinson's Disease Treatment

The study, led by Drs. Ramon L. Rodriguez, Stuart H. Isaacson, Yasar Torres-Yaghi, Rajesh Pahwa, and Ahmad Al-Sabbagh, highlights ongoing challenges related to dosing precision, treatment

More news about: Alora Pharmaceuticals, LLC


Jan 27, 2026, 13:00 ET Go1 Unveils New Product Direction Focused on Contextual Learning, Driving Measurable Outcomes

Go1, the leading learning provider for people-first L&D leaders, releases a new phase of its product strategy focused on delivering contextual, in-the-moment learning directly within the flow of work.

More news about: Go1


Jan 27, 2026, 12:05 ET Defense Stocks Ignite as $900 Billion Pentagon Budget Triggers AI Tech Revolution

miss. This massive structural shift puts a bright spotlight on VisionWave Holdings, Inc. (NASDAQ: VWAV), Leonardo DRS (NASDAQ: DRS), L3Harris Technologies (NYSE: LHX), Mercury Systems (NASDAQ: MRCY), and Cloudastructure (NASDAQ: CSAI).

More news about: Equity Insider


Jan 27, 2026, 12:00 ET ISA Elevates Eight Members to Fellow

automation and control systems, critical infrastructure protection and global advancement of standards, security workforce development.Eloise L. RocheSIS-TECH Solutions, LPFor significant contributions to the process industries functional safety in safety instrumented system

More news about: The International Society of Automation


Jan 27, 2026, 10:03 ET Top Cancer Researchers Join Forces to Advance Development of Therapeutic Cancer Vaccines

the DCVax platform technology: DCVax®-L for operable tumors and DCVax®-Direct for inoperable tumors. To date, NWBio has treated approximately 20 diverse types of solid tumor cancers and has completed a 331-patient international Phase 3 trial of DCVax-L for glioblastoma brain cancer,

More news about: Cancer Vaccine Coalition


Jan 27, 2026, 09:40 ET Skyhawk Therapeutics ogłasza dziewięciomiesięczne wyniki pośrednie badań klinicznych fazy 1 nad lekiem SKY-0515 stosowanym w leczeniu choroby Huntingtona

korzyści płynące z redukcji zmutowanego HTT.Firma Skyhawk poinformowała również dzisiaj, że badanie fazy 2/3 leku SKY-0515 o nazwie FALCON-HD l, prowadzone w dwunastu ośrodkach w Australii i Nowej Zelandii, zostało rozszerzone na cały świat. Jak dotąd lek SKY-0515 podano ponad 90 pacjentom.SKY-0515

More news about: Skyhawk Therapeutics


Jan 27, 2026, 09:30 ET Challenger Center Launches 40th Anniversary, Honoring the Challenger Crew and Inspiring the Next Generation of Explorers

Jan. 27, 2026 /PRNewswire/ -- As the nation approaches the 40th anniversary of the loss of the Challenger STS-51L crew on January 28, 1986,

More news about: Challenger Center For Space Science Education


Jan 27, 2026, 08:46 ET The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age

Gadopiclenol: A New Contrast Agent for MRI of the CNS and Body. Invest Radiol 2024; 59(2):124-130.Kanal E, Maki JH, Schramm P, Marti-Bonmati L. Evolving Characteristics of Gadolinium-Based Contrast Agents for MR Imaging: A Systematic Review of the Importance of Relaxivity. J Magn Reson Imaging

More news about: Bracco Group


Jan 27, 2026, 08:37 ET Dual Platform Options for Critical Single-Use Freeze and Thaw Operations from Meissner

and dispense. Dual platform offerings in both robust flexible biocontainers (50 mL to 10 L) and rigid containers (from 30 mL bench–scale through 75 L bulk drug substance containers and up to 300 L nominal working volume per freezer cycle) give biopharmaceutical manufacturers maximum security and

More news about: Meissner Corporation


Jan 27, 2026, 08:15 ET One Year After DCA Midair Disaster, Families Fight for Accountability

approach to Runway 33 at Reagan National (DCA) on the night of January 29, 2025, when it entered the same airspace as a U.S. Army UH-60L Black Hawk helicopter (PAT25). The aircraft collided and crashed into the Potomac River, killing all 67 people aboard."The NTSB has determined

More news about: Wisner Baum


Jan 27, 2026, 08:10 ET IDCC Named Contracted SCN Partner Through Public Health Solutions' WholeYouNYC

committed to integrating clinical care with social support to improve stability, health outcomes, and quality of life.Press contact:Chelsea L. Ramos(718)307-6800 ext. 428

More news about: Interborough Developmental & Consultation Center (IDCC)


Jan 27, 2026, 08:00 ET Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

first-line regimen) or Olaparib (advanced breast cancer patients with BRCA mutations). Eligibility for the pembrolizumab-containing cohort required PD-L1–positive disease (CPS ≥10), consistent with standard-of-care practice in metastatic TNBC.Patient 1 – Partial ResponseA 61-year-old female

More news about: Kazia Therapeutics Limited


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.